RT Journal Article
T1 Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
A1 De Laurentiis, Michelino
A1 Borstnar, Simona
A1 Campone, Mario
A1 Warner, Ellen
A1 Bofill, Javier Salvador
A1 Jacot, William
A1 Dent, Susan
A1 Martin, Miguel
A1 Ring, Alistair
A1 Cottu, Paul
A1 Lu, Janice
A1 Ciruelos, Eva
A1 Azim, Hamdy A
A1 Chatterjee, Sanjoy
A1 Zhou, Katie
A1 Wu, Jiwen
A1 Menon-Singh, Lakshmi
A1 Zamagni, Claudio
YR 2022
FD 2022
LK https://hdl.handle.net/10668/27207
UL https://hdl.handle.net/10668/27207
LA en
DS RISalud
RD Apr 18, 2025